ATE443512T1 - Pharmazeutische zusammensetzung von piperazinderivaten - Google Patents

Pharmazeutische zusammensetzung von piperazinderivaten

Info

Publication number
ATE443512T1
ATE443512T1 AT05758582T AT05758582T ATE443512T1 AT E443512 T1 ATE443512 T1 AT E443512T1 AT 05758582 T AT05758582 T AT 05758582T AT 05758582 T AT05758582 T AT 05758582T AT E443512 T1 ATE443512 T1 AT E443512T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
piperazine derivatives
piperazine
derivatives
pharmaceutical
Prior art date
Application number
AT05758582T
Other languages
English (en)
Inventor
Domenico Fanara
Jean Scouvart
Claire Poulain
Michel Deelers
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34925743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE443512(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Application granted granted Critical
Publication of ATE443512T1 publication Critical patent/ATE443512T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT05758582T 2004-07-14 2005-07-07 Pharmazeutische zusammensetzung von piperazinderivaten ATE443512T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04016519 2004-07-14
PCT/EP2005/007340 WO2006005507A2 (en) 2004-07-14 2005-07-07 Pharmaceutical composition of piperazine derivatives

Publications (1)

Publication Number Publication Date
ATE443512T1 true ATE443512T1 (de) 2009-10-15

Family

ID=34925743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05758582T ATE443512T1 (de) 2004-07-14 2005-07-07 Pharmazeutische zusammensetzung von piperazinderivaten

Country Status (25)

Country Link
US (1) US8633194B2 (de)
EP (1) EP1768649B1 (de)
JP (1) JP4902875B2 (de)
KR (1) KR101185612B1 (de)
CN (1) CN100508981C (de)
AR (1) AR049846A1 (de)
AT (1) ATE443512T1 (de)
AU (1) AU2005261953B2 (de)
BR (1) BRPI0513257C1 (de)
CA (1) CA2573662A1 (de)
CY (1) CY1109670T1 (de)
DE (1) DE602005016802D1 (de)
EA (1) EA012463B1 (de)
ES (1) ES2332462T3 (de)
IL (1) IL180010A0 (de)
MX (1) MX2007000230A (de)
MY (1) MY149403A (de)
NO (1) NO337768B1 (de)
NZ (1) NZ552182A (de)
PE (1) PE20060484A1 (de)
PL (1) PL1768649T3 (de)
PT (1) PT1768649E (de)
TW (1) TWI304339B (de)
WO (1) WO2006005507A2 (de)
ZA (1) ZA200700939B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2408453B1 (de) 2009-03-17 2022-01-05 Nicox Ophthalmics, Inc. Ophthalmische formulierungen aus cetirizin und verfahren zu ihrer verwendung
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
TWI503122B (zh) * 2012-02-15 2015-10-11 Taiho Pharmaceutical Co Ltd Oral administration of pharmaceutical compositions
KR102155836B1 (ko) 2013-02-22 2020-09-14 삼성전자주식회사 터치 스크린 상에서 객체 디스플레이를 제어하는 휴대 단말 및 방법
US11241426B2 (en) 2017-02-13 2022-02-08 Nitto Medic Co., Ltd. Aqueous composition for ophthalmic or nasal administration
CN113712907A (zh) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 一种盐酸左西替利嗪滴眼液组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255358A (en) * 1978-03-13 1981-03-10 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Process for the production of hexanitrostilbene
FI75816C (fi) 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
US4728509A (en) * 1985-08-19 1988-03-01 Takeda Chemical Industries, Ltd. Aqueous liquid preparation
JP3278192B2 (ja) * 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
TW401300B (en) 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5504113A (en) * 1994-03-02 1996-04-02 Allergan, Inc. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
CA2201134A1 (en) * 1994-10-10 1996-04-18 Alfred Sallmann Ophthalmic and aural compositions containing diclofenac potassium
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
US6432961B1 (en) * 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
AUPQ419099A0 (en) * 1999-11-23 1999-12-16 Ko, Thomas Sai Ying Novel compositions and methods
DE10007203A1 (de) * 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
AU2002221854A1 (en) 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
US6869618B2 (en) * 2001-04-10 2005-03-22 Kiel Laboratories, Inc. Process for preparing tannate liquid and semi-solid dosage forms
CA2488202C (en) * 2002-06-12 2011-03-08 Chemocentryx, Inc. 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
AU2003251152A1 (en) 2002-07-03 2004-01-23 Shannon Biotechnology Ltd Pharmaceutical formulations for preparing drink products
EP1569650B1 (de) 2002-12-03 2008-05-28 Ucb Farchim S.A. Verwendung von levocetirizin zur behandlung von persistierender allergischer rhinitis
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US20090137645A1 (en) * 2007-10-31 2009-05-28 Midlothian Laboratories, Llc Shelf-Stable Famotidine Granulates for Oral Suspensions

Also Published As

Publication number Publication date
BRPI0513257B1 (pt) 2018-05-29
EA200700067A1 (ru) 2007-08-31
CA2573662A1 (en) 2006-01-19
AU2005261953B2 (en) 2010-06-03
NO337768B1 (no) 2016-06-20
EP1768649B1 (de) 2009-09-23
TWI304339B (en) 2008-12-21
US20070275974A1 (en) 2007-11-29
DE602005016802D1 (de) 2009-11-05
JP2008505949A (ja) 2008-02-28
AU2005261953A1 (en) 2006-01-19
BRPI0513257C1 (pt) 2021-05-25
PE20060484A1 (es) 2006-07-06
KR20070043841A (ko) 2007-04-25
CY1109670T1 (el) 2014-08-13
MY149403A (en) 2013-08-30
NZ552182A (en) 2010-07-30
HK1103958A1 (zh) 2008-01-04
CN1984641A (zh) 2007-06-20
EP1768649A2 (de) 2007-04-04
WO2006005507A8 (en) 2006-12-07
WO2006005507A3 (en) 2006-04-27
JP4902875B2 (ja) 2012-03-21
ES2332462T3 (es) 2010-02-05
US8633194B2 (en) 2014-01-21
PL1768649T3 (pl) 2010-02-26
IL180010A0 (en) 2007-05-15
CN100508981C (zh) 2009-07-08
NO20070832L (no) 2007-02-13
EA012463B1 (ru) 2009-10-30
KR101185612B1 (ko) 2012-09-24
ZA200700939B (en) 2008-08-27
AR049846A1 (es) 2006-09-06
WO2006005507A2 (en) 2006-01-19
PT1768649E (pt) 2009-11-13
BRPI0513257A (pt) 2008-04-29
MX2007000230A (es) 2007-03-30
TW200605892A (en) 2006-02-16

Similar Documents

Publication Publication Date Title
EP1748765A4 (de) Pharmazeutische suspensionszusammensetzung
CY2017048I1 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
HUS1400051I1 (hu) Lurazidont tartalmazó gyógyászati készítmény
BRPI0508259A (pt) derivado heterocìclico fundido, composição medicinal contendo o mesmo, e uso medicinal do mesmo
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
DK1587478T3 (da) Farmaceutisk sammensætning
DE60332393D1 (de) Flüssige pharmazeutische zusammensetzung mit pyridonderivaten
DK1725218T3 (da) Farmaceutisk sammensætning omfattende pimobendan
DE602005005456D1 (de) Neue azabicyclische derivate, herstellungsverfahren dafür und sie enthaltende pharmazeutische zusammensetzungen
ATE538125T1 (de) Neue 2-azaindol-derivate, deren herstellung und pharmazeutische verwendung als kinase-inhibitoren
ATE443512T1 (de) Pharmazeutische zusammensetzung von piperazinderivaten
BRPI0611748A2 (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
SM200500011A (it) Una composizione farmaceutica antimicobatterica
DE502004009045D1 (de) Injizierbare darreichungsform von flupirtin
DE60328787D1 (de) Pharmazeutische salze von reboxetin
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
ATE489943T1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate
ATE349213T1 (de) Nasale pharmazeutische zusammensetzung von piribedil
EP1747205A4 (de) Pharmazeutische zusammensetzungen
DE602005005033D1 (de) Sprühgetrocknete pharmazeutische zusammensetzungen
ATE439841T1 (de) Pharmazeutische zusammensetzungen mit zd6474
PT1467737E (pt) Composicao farmaceutica orodispersivel de piribedil
ATE359776T1 (de) Kombination von arzneimitteln gegen diabetes
ATE428416T1 (de) Feste pharmazeutische zubereitung enthaltend (r)- (-)-2-ä5-(4-fluorophenyl)-3- pyridylmethylaminomethylü-chroman
SE0401972D0 (sv) Piperazine derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1768649

Country of ref document: EP